FDA says that drug developers are interested in applying (quantitative) structure-activity relationship models that have been improved by agency resea...
FDA issues an immediately-in-effect guidance to help address manufacturing limitations or supply chain issues arising from the Covid-19 public health ...
FDA releases a list of antibody tests that the agency expects will not be marketed or distributed for several reasons.
The FDA Sentinel Operations Center at the Harvard Pilgrim Health Care Institute is working with TriNetX on projects to assess usage of medications use...
Biota Biosciences recalls five lots of Cannabidiol Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables because they were marketed withou...
Stericycle says medical device and drug manufacturers should expect a significant uptake in FDA regulatory and enforcement action once the nation move...
Four stakeholders give FDA recommendations for changes to a draft guidance on flow restrictors for oral liquid drug products.
Federal Register notice: FDA announces the renewal of the Arthritis Advisory Committee for an additional two years beyond the charter expiration date.